A New WHO Mega-Map Shows Where Age-Friendly Evidence Exists—and Where It Does Not

Making a neighbourhood easier to navigate, a transport system more accessible or a public space safer can influence how well people age. Yet evidence about these changes is spread across many sectors and research databases. A new global mega-map from the World Health Organization aims to make that evidence easier to find.

The resource, launched on 5 November 2026, brings together systematic reviews and evidence-and-gap maps covering interventions and programmes for age-friendly environments. It spans areas such as housing, transport, public space and community participation.

What a mega-map actually does

A mega-map is a structured overview of existing evidence. Instead of combining individual study results into one pooled estimate, it organizes systematic reviews and other evidence maps across a broad policy area. Users can explore which topics have been studied, where reviews are concentrated and where important gaps remain.

That distinction is essential. The map shows where evidence is available; it does not automatically show that every listed intervention is effective. A cluster of reviews may reveal a mature research area, but the quality and conclusions of those reviews still need to be examined. An empty area may indicate a research gap rather than proof that an intervention does not work.

Why age-friendly environments cross several sectors

Healthy ageing is shaped by more than medical care. The design of streets, buildings and transport can affect mobility and independence. Access to community spaces can influence social participation. Housing quality can change exposure to falls, heat, cold and other risks.

These factors are connected. A person may have access to a well-designed park but still be unable to reach it safely. Public transport may be affordable but difficult to board. A community centre may offer valuable activities while inaccessible entrances or poor information limit participation.

Because responsibility is divided among health, housing, planning, transport and social services, decision-makers often struggle to see the full evidence landscape. A shared map can help different sectors start from the same inventory.

How the tool can support decisions

For policymakers and local authorities, the mega-map can be a starting point for a focused evidence review. It may help teams identify systematic reviews relevant to a planned intervention, compare research coverage across domains and decide where additional evaluation is most needed.

For researchers and funders, visible gaps can guide future work. If an important issue has few high-quality reviews, that may justify new synthesis or primary research. If many reviews already exist, the priority may shift toward assessing quality, updating outdated work or improving implementation.

For practitioners, the resource can reduce the time required to locate relevant evidence. It cannot replace local assessment, however. An intervention studied in one transport system, climate or housing context may not transfer directly to another.

Questions to ask before using mapped evidence

  • What population was included? Older adults are not a single, uniform group. Mobility, income, disability, location and social support can alter both needs and outcomes.
  • How recent is the review? Urban design, digital access and transport options can change quickly.
  • What outcome was measured? Accessibility, physical activity, social connection, safety and quality of life are related but not interchangeable.
  • Was implementation evaluated? A promising intervention may fail when maintenance, affordability or community involvement is missing.
  • Were older people involved? Age-friendly planning should include the people most affected, not only technical experts.

A map for better questions, not a shortcut to certainty

The new WHO resource is useful because it makes a fragmented field more navigable. Its greatest value may be helping users ask better questions: Which interventions have been reviewed? Which groups or settings are missing? Where is the evidence strong enough to inform action, and where should policy be paired with careful evaluation?

Age-friendly environments require long-term work across sectors. A mega-map cannot decide priorities for a city or community. It can, however, make the evidence trail clearer and reduce the chance that decisions begin with only the most visible or easiest-to-find studies.


Sources: WHO launch event and WHO evidence and gap maps for the UN Decade of Healthy Ageing.

Featured image: Daniel Silva / Unsplash License.

Sign up to our
weekly newsletter

    More Articles

    - Advertisement -spot_img

    Two Ebola Vaccine Candidates Enter an Outbreak Trial: What Is Known—and Still Unknown

    WHO advisers recommended adding two Bundibugyo-specific Ebola vaccine candidates to an ongoing outbreak trial in the DRC. They remain investigational.

    Bone Health After 50: What Screening, Strength Training and Nutrition Can—and Cannot—Do

    Bone loss is often silent until a fracture occurs. Here is what current NIH guidance says about risk, DXA screening, exercise and nutrition—and where individual medical advice still matters.